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Abstract
Objective To characterize shifts from the 1960s to the first
decade in the 21st century as to diagnostics, case-mix, and
surgical management of pediatric patients undergoing perma-
nent CSF diversion procedures.
Methods One hundred and thirty-four patients below 15 years of
age were the first time treated with CSF shunt or ETV for hy-
drocephalus or idiopathic intracranial hypertension (IIH) in
2009–2013. This represents our current practice. Our previously
reported cohorts of shunted children 1967–1970 (n = 128) and
1985–1988 (n = 138) served as backgrounds for comparison.
Results In the 1960s, ventriculography and head circumference
measurements were the main diagnostic tools; ventriculoatrial
shunt was the preferred procedure (94 %), neural tube defect
(NTD) was the leading etiology (33 %), and overall 2-year sur-
vival rate was 76 % (non-tumor survival 84 %). In the 1980s,
computerized tomography (CT) was the preferred diagnostic im-
aging tool; ventriculoperitoneal shunt (VPS) had become stan-
dard (91 %), the proportion of NTD children declined to 17 %,
and the 2-year survival ratewas 91% (non-tumor survival 95%).
Hydrocephalus caused by intracranial hemorrhage had, on the
other hand, increased from 7 to 19 %. In the years 2009–2013,
when MRI and endoscopic third ventriculocisternostomy (ETV)
were matured technologies, 73 % underwent VPS, and 23 %
ETV as their initial surgical procedure. The most prevalent
etiology wasCNS tumor (31%). The proportion ofNTD patients
was yet again halved to 8%, while intracranial hemorrhagewas
also reduced to 12%. In this last period, six children were treated
with VPS for Idiopathic Intracranial Hypertension (IIH) due to
unsatisfactory response to medical treatment. They all had head-
ache, papilledema, and visual disturbances and responded favor-
ably to treatment. The 2 years of survival was 92 % (non-tumor
survival 99 %). In contrast to the previous periods, there was no
early shunt related mortality (2 years). Aqueductal stenosiswas a
small but distinctive group in all cohorts with 5, 6 and 3 %
respectively.
Conclusions The case-mix in pediatric patients treated with
permanent CSF diversion has changed over the last half-centu-
ry. With the higher proportion of children with CNS tumor
patients and inclusion of the IIH children, the median age at
initial surgery has shifted substantially from 3.2 to 14 months.
Between the 1960s and the current cohort, 2 years of all-cause
mortality fell from 24 to 8%. Prolonged asymptomatic periods,
extending 15 years, were relatively common. Nevertheless, 18
patients experienced shunt failure more than 15 years after last
revision, and first-time shunt failure has been observed 29 years
after initial treatment. This underscores the importance of life-
long follow-up.
Keywords Pediatric CSF diversion . Shifts in case-mix and
management
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Introduction
Despite significant advances that have transpired in the treat-
ment of hydrocephalus during the last six decades, most neu-
rosurgeons still regard the management of pediatric hydro-
cephalus as a challenge. Albeit hydrocephalus has been clin-
ically recognized since antiquity; the current understanding of
its pathophysiology is mainly a product of the 19th and 20th
centuries [1]. In a classical study, largely valid even today,
Key and Retzius in 1875 suggested that the cerebrospinal fluid
(CSF) was secreted by the choroid plexus, flowed out of the
ventricular system, and was reabsorbed through the subarach-
noid villi and pacchionian granulations [1]. Once hydroceph-
alus was recognized as a mechanical hydraulic disorder, it was
realized that theoretically treatment might be through any of
the following three means: reducing CSF production by
deactivating the choroid plexus, reopening intracerebral
blocked fluid pathways with a bypass or a surgical removal
of the causative lesion, or shunting CSF into body cavities of
normally low pressure using a valved tubing system.
Today’s treatment has resulted from discoveries within nu-
merous fields underlining an inextricable mutual bond be-
tween basic science and clinical therapy.
Before CSF shunting became common, i.e., in the 1940–
1950s, the mortality rate was about 50 % (about one in two
children died), and many of the survivors has debilitating deficits
[2]. Technological breakthroughs made silicon shunts possible,
providing biocompatibilities [1, 3]. At the same time, improved
valve technology emerged which explains why between 1956
and 1961 valved shunts had become standard of care [1].
It soon transpired, however, that in most cases shunt sur-
gery could relieve the acute life-threatening disorder while
converting it to a chronic condition. Nowadays, mortality is
mostly due to the underlying cause of hydrocephalus.
For a period, ventriculoatrial shunts (VAS) were standard,
superseded by ventriculoperitoneal shunts (VPS) from about
1980.
In our department, Arne Torkildsen introduced
ventriculocisternostomy in 1937 using rubber catheters.
These proved to be effective in selected cases [4]. Following
the advent of reliable valved shunts, ventriculocisternostomy
was performed only occasionally, but since the 1990s ad-
vanced neuroendoscopic techniques have resulted in a renais-
sance of ventriculostomy.
We have chosen a procedure-centered focus rather than
concentrating on a more or less well-defined disease entity.
The aim of the present work is thus to portray some long lines
from the evolving practice of CSF diversion procedures. To
this end, we present representative snapshots from three dif-
ferent epochs spanning one-half century of pediatric CSF di-
version surgery from the 1960s until today.
Material and methods
All patients under 15 years of age who underwent initial treat-
ment for hydrocephalus and IIH with either a prosthetic shunt
system or endoscopic third ventriculocisternostomy (ETV), in
the Neurosurgical Department, Oslo University Hospital,
Oslo, Norway, between 01 January 2009 and 31 December
2013, were retrospectively analyzed. The patients were select-
ed from surgical protocols according to the NOMESCO
(Nordic Medico-Statistical Committee) classification of surgi-
cal procedures (NCSP) [5]. The codes selected were the
following: ventriculostomy (AAF00), ventriculoperitoneal
shunt (AAF05), lumboperitoneal shunt (AAF10),
ventriculoatrial shunt (AAF15), shunt of intracranial cysts to
peritoneum (AAF40), and other shunt operation (AAF99)
(Subduroperitoneal shunt), i.e., all types of prosthetic shunts,
and ETV procedures were included. The diagnose of hydro-
cephalus was based on increased head circumference, typical
clinical signs of raised intracranial pressure, and enlargement
of the ventricular system on neuroradiological imaging; and in
ambiguous cases, intracranial pressure (ICP) recording was
used. All the IIH patients had papilledema, and the indication
for shunting was stationary or progressive visual field defects
despite medical treatment, intractable headache, or both.
The following details were ascertained from the case
records: name, age, gender, indication of initial permanent
CSF diversion, later CSF diversion procedures, hardware
removal with subsequent re-implantation, surgical compli-
cations (e.g., shunt infection), survival, and cause of
death. CSF diversion procedures due to presumed treat-
ment failure were performed in the presence of moderate
to severe clinical symptoms of shunt dysfunction, in most
cases, supported by radiological findings. In some patients
with vague clinical symptoms and/or non-conclusive ra-
diological findings, ICP monitoring was used to verify the
presence of drainage failure, (over- or under drainage) or
not, prior to revision.
Two previous cohorts of children, both including children
younger than 15 years of age, initially shunted for hydroceph-
alus in the same institution during the years between 1967–
1970 (n = 128) and 1985–1988 (n = 138) and formed the basis
for our comparison [6, 7].
The results from these three time epochs were used to
describe our experience as well as shifts in diagnostic
work-up, case-mix, and surgical management during half
a century.
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Statistics
These cohorts include children considered to be in need for
CSF diversion referred to our department in the actual time
periods. There are obvious differences as to case-mix and
surgical approach. Besides, we assume that there are unknown
confounders. Statistical probability analysis may therefore
seem inappropriate and has therefore not been performed.
Results
Recent cohort
In this first section, we present results from children treated
with CSF shunt or ETV in the calendar years 2009–2013. We
identified 134 patients (81 males, 53 females) first time treated
with CSF shunting or ETV in our department in 5 years, 2009
to 2013. The patients were followed between 2 and 7 years or
until death - follow-up was complete in all cases. Last avail-
able follow-up was at an average of 8 years 4 months (median
6 years 10 months, range 2.5 to 20.5 years).
The cause of intracranial hypertension is summarized in
Table 1. The most common underlying condition was CNS
neoplasm (31 %). The vast majority of children in need for
CSF diversion in the Hemorrhage (12 %) group were infants,
born preterm with intraventricular or/and intracerebral hemor-
rhage. Neural tube defects (NTD) accounted for 8 % of the
children. The group, here referred to as Other malformation
(22 %), included a wide range of causes, see Table 1. Patients
with IIH accounted for six patients (4%). Other children with-
out any obvious cause to their elevated ICP were denoted as
Unknown (17 %).
The mean age at first-time treatment (prosthetic shunt or
ETV) was 3 years 11 months (median 1 year 2 months, range
1 day to 14 years 12 months). In 43 (32 %) patients, first
treatment was performed during their first 6 months of life;
and in 64 (48 %) patients, within the first year of life. Time of
initial treatment varied considerable within the different sub-
groups; whereas, the mean age was 6 years 11 months (medi-
an 6 years 11 months) in the Tumor group and 6 months (me-
dian 10 days) in the NTD group. If excluding the patients with
Tumor and IIH, the mean age at first surgical treatment for
hydrocephalus was 2 years 1 month (median 7 months).
Within 2 years of initial surgery (prosthetic shunt or ETV),
more than half of the patients (52 %) needed to undergo at
least one re-do. Repeat surgery was more frequent in the
Hemorrhage group (mean 2.4), lower in the Tumor group
(mean 1.1), while no revisions were performed in the three
patients with hydrocephalus due to Infection. In total, 59/134
(44 %) patients did not require further hydrocephalus-related
surgery, and 51/118 (43 %) of whom were alive at follow-up.
Patients initially treated with a prosthetic shunt
In 103 (77 %) patients, a prosthetic shunt was placed to treat
the child’s intracranial hypertension (98 VPS, 2 CPS, 1 LPS,
2 S-DPS). All of whom had clinical symptoms indicating
raised intracranial pressure and the vast majority presented
with ventriculomegaly on neuroimaging. In some patients
ICP recording was used as an adjuvant diagnostic procedure
prior to permanent CSF diversion. Furthermore, continuous
over-night ICP-recording was used for all the 6 IIH patients
to reveal mean ICP pressure and mean wave amplitudes. The
mean age at shunt insertion was 3 years 8 months (median
11 months, range 1 day to 14years 7 months). The proportion
of children without any revision of initial shunt between 1 and
Table 1 The underlying cause for permanent CSF diversion in 134
pediatric patients during the calendar years 2009–2013
Cause No. of patients (%)




Supra- and infratentorial loc. 2
Intraspinal neoplasms 1
NF type 1/TS 3
Hemorrhage 16 (12)
IVH and/or ICH 13
SAH/other vascular malformations 2
Acute subdural hemorrhage 1






Aqueductal stenosis 4 (3)
Other malformations 29 (22)
Syndromal associated HC 11
Intracranial cysts




Dermal sinus tract 1




Idiopatic intracranial hypertension (IIH) 6 (4)
Total 134 (100)
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2 years was 53 % (52/98) and 44 % (41/94), respectively. In
times of shunt failure, eight patients were treated with ETV.
Two of them did not need further treatment, while six later
received a prosthetic shunt. At follow-up (2–7 years), 89 out
of 103 initially shunted children were still alive. Twenty-five
of these (28%) had no revision of their prosthetic shunt during
the study period.
Idiopatic intracranial hypertension (IIH) was the cause of
shunt placement in six patients (three boys, three girls). The
mean age at shunt insertion (VPS) was 9 years (median 9 years
8 months, range 4 years to 12 years 3 months). Due to further
worsening of vision despite shunt placement, orbitotomy was
performed bilaterally in one male patient followed by 11 shunt
revisions during follow-up. In the remaining five patients,
only one revision was registered. Except from one female
patient who in the following has been diagnosed with a hered-
itary eye condition, the remaining patients reported relief of
headaches, improved vision and resolution of chocked disks.
ETV as initial treatment
In 31 (23 %) patients, ETV was the preferred choice of initial
surgery. Almost half of them (15 children) had intracranial
tumor, of which ten in the posterior fossa. The patients being
primarily treated with ETV tended to be slightly older than the
individuals first time treated with a prosthetic shunt system
with amean age of 4 years 7months (median 1 year 6months).
Two patients, both with malignant tumor, died within 2 years
of follow-up.
The proportion of children with no re-dos (repeat ETV or
conversion to prosthetic shunt) at 1 and 2 years was 67 % (20/
30) and 62% (18/29), respectively. Mean revision-free time in
those 11 patients who needed further revisions was 5 months
(median 2 months, range 1 day to 2 years). In one patient, a re-
stoma was successfully performed, while in the remaining ten
patients, VPS was placed.
Shunt related morbidity and mortality
Two hundred and thirty-three surgical procedures (shunt revi-
sions, ETVs, and re-ETVs), with a range of 1–14 procedures
for each of the affected children, were recorded. Shunt
infection did occur in 14 cases in 12 (9 %) patients, with an
incidence of infection per procedure of 3.8 %.
Of the 134 patients evaluated, 16 (12 %) died during fol-
low-up. Analyses revealed survival rates of 98.5, 95.5, and
91.8 at 0.5, 1, and 2 years, respectively (form initial treatment
until death), see Table 2. In all 16 cases, the most probable
cause of death was due to their underlying condition; 15 pa-
tients died due to malignant CNS tumors, and one patient
shunted in palliative care died due to severe malformations
(anencephaly).
Excluding the tumor patients revealed, survival rate was at
100 % at 1 year and 99 % (91/92) at 2 years.
Patients with CNS tumor
In total, 42/134 (31 %) patients had hydrocephalus associated
with CNS tumor. This subgroup differs from the others due to
the high mortality rate of 15/42 (36 %), and age at initial
treatment. We found a predominance of boys with a
male/female ratio of 24/18 = 1.33. There was an even distri-
bution of patients with tumor located supra- and
infratentorially (21/42, 50 %), and there was a predominance
of high-gradeWHO III/IV (24/42, 57 %) tumors. Except from
eight patients, all with low-grade tumors, the remaining 34
patients had adjuvant chemo- and/or radiotherapy.
Endoscopic third ventriculocisternostomy was selected as
initial intervention for the child’s hydrocephalus in 15/42
(36 %) instances. In all 15 patients, nine of whom had an
infratentorial location of their tumor, intracranial hypertension
was relieved before tumor surgery. Preoperative ETV was
persistently successful in 12 patients, and three patients were
in need for re-surgery due to their hydrocephalus; in one pa-
tient, a re-stoma was subsequently performed, while in the
remaining two patients, a VP-shunt was inserted.
Prosthetic shunt systems (VP) were inserted in the latter 27
tumor patients, before (14 patients) or after (13 patients) tumor
resection.
Comparison of results in the three different cohorts—from
the 1960s, 1980s, and the twenty-first century
The cause of the hydrocephalic state raised intracranial pres-
sure in pediatric patients differs greatly in the three cohorts
Table 2 Survival rates in
pediatric patients treated with
permanent CSF diversion in three
different time epochs
No. of patients (non-tumor) Overall survival rates (non-tumor)
Time epoch At 1 year At 2 years
1967–1970 128 (103) 84 (88) 76 (84)
1985–1988 138 (115) 93 (96) 91 (95)
2009–2013 134 (92) 96 (100) 92 (99)
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studied. Table 3 gives a brief overview of our major findings.
Males outnumbered females in all three cohorts with a
male/female ratio of 1.2, 1.9, and 1.5, respectively. Figure 1
demonstrates the etiological factors for each given time epoch.
In the 1960s, NTD was accounting for one third of the chil-
dren requiring shunt insertion [7]; in the 1980s, the proportion
was nearly halved to 17 percentages [6], and in the twenty-
first century, the proportion of children was only 8 %.
Hemorrhage was the cause of shunting in 7 % in the 1960s,
increased to 19 % in the 1980s, and reduced to 12 % in the
years 2009–2013 [6, 7]. Themost common distinct etiological
group in the third cohort was CNS neoplasm (31 %) which
accounted for 20 and 17 % in the first and second period.
Aqueductal stenosis was a small but distinctive group in all
the cohorts with 5, 6, and 3 %, respectively. Consequently,
there were divergent results regarding age at initial treatment
in the three cohorts. The median age in the most recent cohort
was 14 months, compared to 6 months in the 80s, and
3.2 months in the 60s.
Our findings concerning preferred initial surgical treat-
ment in children with HC raised intracranial pressure are
illustrated in Fig. 2. VA shunt was the initial surgical
procedure in 94 % of the cases in our study conducted
in the 1960s. In the 1980s, VP shunts was the most com-
mon procedure and accounted for 91 %, and the propor-
tion treated with VA shunts had diminished to 4 %. In the
third cohort from the twenty-first century, 73 %
underwent VPS and 23 % ETV as the first surgical treat-
ment due to raised intracranial pressure.
Event-free survival rate of the primary shunt at 2 years in
children treated in the late 60s was 34 % (33 patients of 97
still-alive patients). Excluding elective elongations of the atrial
catheters, 42 % of the patients had not experienced shunt
failure. In the cohort treated in 1985–88, event-free survival
rate after 2 years was 40 % (50 patients of 125 still-alive
patients), and in the cohort from 2009 to 2013, event-free
survival rate of initial treatment (prosthetic shunt or ETV) at
2 years was 48 %.
Table 3 Comparison of three cohorts of children treated with permanent CSF diversion in different time epochs
Time epoch
Variable 1967–1970 1985–1988 2009–2013
Cohort (no. patients) 128 138 134
Follow up (years) 42–45 20–24 2–7
Median age at follow up (years) 44.6 23.6 6.8
Diagnostic work-upa Ventriculography CT CT/MR
Demography Median age, initial
treatment (months)
3.2 6 14
sex-ratio (M/F) 1.2 1.9 1.5
Etiology (%) Determined Neural tube defect 33 17 8
Hemorrhage 7 19 12
CNS neoplasm 20 17 31
Aqueductal stenosis 5 6 3
Postinfectious 2 6 2
Other malformationsb 9 18 22
IIH 0 0 4
Trauma 0 3 0
Undetermined Unknownb 24 14 17
Event-free survival (%)c at 1 year 64 61 56
of the shunt at 2 years 42 40 48
Mortality (%) Overall at 1 year 16 7 4
at 2 years 24 9 8
Non-tumoral at 1 year 12 4 –
at 2 years 16 5 1
Mortality (no) Shunt-related at 2 years 4 1 –
a Besides head circumference measurements and clinical signs, this was the most common used neuroimaging technique at time of inclusion
b Patients amounting for the Congenital communicating HC-group in the cohort from the 1960s were included in the Unknown-group, while patients
shunted due to posterior fossa cysts/porencephaly, multiple malformations, chromosome defect, Arnold-Chiari malformation, and CNS disease in the
late 1960s were included in the Other malformation-group
c Elective shunt revisions are excluded
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The overall and non-tumor survival rates (between 1 and
2 years) in the three different time epochs are presented in
Table 2.
A long interval between episodes of shunt failure was seen
in a number of cases. Fifteen patients in the cohort from the
late 1960s and three patients in the cohort from the 1980s
experienced stable shunt function for 15 years or more, where
after shunt failure occurred. Additionally, one patient experi-
enced first-time shunt failure no less than 29.2 years after
initial treatment. This patient had intracranial hemorrhage fol-
lowing intake of amphetamine.
Discussion
This report includes all pediatric patients who received per-
manent CSF diversion during 2009–2013. All patients pre-

























Fig. 1 Case-mix in children less
than 15 years of age are in need
for permanent CSF diversion
(prosthetic shunt or ETV) due to


























Fig. 2 CSF-shunting in pediatric
hydrocephalus patients changing
practice patterns 1967–2013
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raised intracranial pressure, and the vast majority had mild to
severe ventricular enlargement on neuro-imaging. The six pa-
tients diagnosed with IIH presented with small or Bnormal
sized^ ventricles according to their age. The inclusion of IIH
patients may be found controversial by some colleagues
claiming that these patients differ from the traditional concept
of hydrocephalus. Still, the need for CSF diversion was evi-
dent in both entities; and since, there was no children with IIH
(Pseudotumor cerebri or benign intracranial hypertension) in
our previous two cohorts in the years 1967–1970 and 1985–
1988, we found them most proper to include in this historical
review, not least, as a supplement for describing differences in
case-mix throughout time.
In Norway, as in Sweden and other western countries, the
incidence of NTD has decreased over the past decades.
Nikkilä et al. did perform a population-based study in
Sweden covering the years from 1973 to 2003 showing that
the rate of spina bifida in newborns diminished gradually from
0.55 to 0.29 per 1000 [8]. In theUSA, between 1970 and 1989,
the neural tube defect rate declined from 1.3 to 0.6 per 1000
births [9]. The decline is probably, to a great extent, a conse-
quence of prenatal ultrasound screening and selective abortion
of affected fetus. Better nutritional intake, usage of folic acid
supplement before and during early pregnancy, amniocente-
sis, and screening for alpha-fetoprotein may also have been
contributing factors [9, 10]. The gradual decreasing number of
shunted individuals with NTD in our three cohorts from the
1960s, the 1980s and further, or until today corroborate with
their findings [6, 7].
The advances in neonatal intensive care seen during the
1970s and 1980s reduced perinatal mortality, and more very
preterm infants with IVH survived and developed hydroceph-
alus [11]. Consequently, we encountered more preterm new-
borns with IVH in need for CSF diversion in the 1985–1988
compared to in the 1967–1970. Despite a continued reduction
in perinatal mortality throughout the 1990s, the prevalence of
hydrocephalus in infants born very preterm decreased. This
was most likely due to improved peri and neonatal care, de-
scribed by Fernell et al. [12]. The reduced number of new-
borns in the most recent cohort in need for CSF diversion due
to IVH corroborates with those findings.
Summarizing the proportion of patients with NTDs and
Hemorrhage in need for permanent CSF diversion in 1967–
1970 and 2009–2013, we find that this proportion has been
halved during a time span of 50 years, from 40 to 20%. At the
same time, in the cohort from the twenty-first century, we
found a higher proportion of hydrocephalus associated with
CNS tumor compared with our previous series [6, 7]. Some
studies have found a gradual increase in the incidence of pe-
diatric brain tumors during the last decades [13]. In the USA, a
similar increase in childhood brain tumors was reported oc-
curring in the mid-1980s and was explained by an increase,
primarily in the detection and reporting of low-grade
astrocytomas secondary to improved diagnosis and registra-
tion [14]. Likewise, an increase in pediatric brain tumors has
also been found in Norway in recent years [15].
During the past five decades, there has been a national
increase in the number of hospitals with a neurosurgical care
unit, and changes has been made regarding the national geo-
graphical distribution of pediatric patients with brain tumor.
Therefore, the higher proportion of CNS tumor in this cohort
does not necessarily indicate a higher annual incidence of
pediatric brain tumors. Yet, our studies only concern
hydrocephalic CNS tumor patients. Due-Tønnessen et al. per-
formed a study on 100 consecutive children surgically treated
for low-grade cerebellar astrocytomas where 15 % experi-
enced a persistent hydrocephalic problem after resection of
the tumor [16].
Comparing the three cohorts did reveal a step-wise increase
in age at initial treatment. The changing case-mix represented
by fewer patients, with NTD and preterm neonates with IVH
in need of CSF diversion, explain some of this difference.
Further, patients with CNS neoplasm and IIH contribute to
increasing the average age. Since the decision for CSF diver-
sion is made by the surgeon on an individual basis, a change in
policy over time cannot be fully excluded.
Surgical management
Since the late 1950s, hydrocephalus treatment became more
standardized, and shunts into the venous system (usually into
the right atrium) were the preferred procedure. Not surprising-
ly, 94 % of the shunts in 1967–1970 were VAS. Nevertheless,
the unavoidable problem of children with longitudinal growth
caused gradual retraction of the atrial catheter and serious side
effects such as thromboembolic events, pulmonal hyperten-
sion, shunt nephritis and sepsis, which led to a negative trend
[17–19]. In the 1970s, the use of VP shunts steadily gained
ground, and it became the most commonly used variety of
shunt. Figure 2 clearly illustrates this shifting practice, and
in 1985–1988, we found that 91 % was VPS. Progress in
neuroendoscopic technique has been one important contribu-
tor to the fact that ETV has gained widespread acceptance as
an effective way to manage hydrocephalus in selected pediat-
ric patients. Kulkarni et al. [20] did show that age, etiology,
and the presence of previous CSF shunt were each important
and independent factors in predicting success of ETV in chil-
dren and thereby have proposed an ETV success score calcu-
lated on these three strata. However, Buxton et al. [21] report-
ed a 23 % success rate in a group of children (with communi-
cating and non-communicating HC) less than 1 year of age
(mean age 3.7 months) and suggested that, despite the fact that
the majority fail, ETV should be considered as the first-line
treatment for hydrocephalus in this age group to spare some
individuals the added morbidity of having a shunt (avoid fu-
ture shunt-related morbidity). Drake et al. conducted a
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multicenter study in Canada including 368 pediatric HC pa-
tients (34 % brain tumors) and found a 1-year ETV success
rate of 65 %, when successful outcome hinged on the absence
of further CSF diversion procedures [22].
In our most recent cohort, 38 % of the ETV patients had
undergone subsequent surgical procedure for CSF diversion
within 2 years. This does not imply a 2-year success rate of
62 %, since 15 out of 31 were tumor patients who underwent
initial ETV before tumor removal. Previous reports have dem-
onstrated that the cure rate of hydrocephalus in children with
tumor in the posterior fossa was 59 % after tumor resection
alone [23]. In our series, two of these patients died within the
2-year period, while some of the other 13 most probably were
cured for their hydrocephalic problem after tumor removal.
On the other hand it seems clear that the ETV eliminated the
acute hydrocephalic problem before tumor surgery.
In some cases of secondary hydrocephalus, improvement
may appear after treatment of primary cause due to the rees-
tablishment of CSF pathways. This may cause overestimation
of ETV success rate and should therefore be taken into ac-
count when comparing ETVoutcome.
Nevertheless, treatment with valved shunts has remained
the most common procedure in recent years. Our 2009–2013
cohort reveals that VP shunts are used in almost three fourths
of the children.
Re-do surgeries
In the most recent cohort, the tumor patients had a lower
revisions rate compared to the other etiological subgroups.
This could be due to the average shorter observational time
caused by deaths shortly after initial treatment, and the fact
that some patients, especially those with infratentorial tumors,
were cured for their hydrocephalic condition after resection of
its origin (tumor).
Pediatric shunt failure rates may be one of several param-
eters used to evaluate the treatment standard. When VAS was
the treatment of choice, elective revisions for lengthening of
the atrial catheter were needed in times of growth of the child,
whereas the necessity of elective elongations became rarer/
non-existing after the introduction of VPS. Moreover, there
are essential differences in terms of shunt hardware and the
availability of diagnostic tools in our three series which make
the comparison challenging. Consequently, comparing revi-
sion rate and event-free shunt survival to investigate whether
any progress has been made in preventing shunt failure over
the past decades are contaminated by differences in practice.
Besides, the high early mortality rate in our study on children
shunted in the late 1960s, and the high proportion of success-
fully procedures with CSF diversion among the tumor patients
prior to resection of tumor in the posterior fossa in the most
recent cohort may both influence our results. Thus, consider-
ing our results regarding shunt survival rate at 2 years of 42,
40, and 48 %, in the first, second, and third period, respective-
ly, the results has not clearly improved.
Similar findings were presented by Stein et al. [24] who
performed a structured search in the literature to determine
whether failure rates of hydrocephalus shunts had fallen in
the period from the late 60s and up until the twentieth century,
excluding elective lengthening of VAS, where they concluded
that no convincing evidence in a reduction of pediatric shunt
failure rates were found.
In our two previous series (1967–1970 and 1985–1988),
both with more than 20 years of observation, more than one
out of ten patients being shunt dependent at follow-up expe-
rienced shunt failure after 15 years or more. This substantiates
the need for lifelong follow-up.
Early mortality
Due to limited observational time in our latest study, this
makes us unable to calculate mortality rates extending 2 years
of duration. Since our results from the late 1960s did reveal
rather discouraging findings concerning overall short-term
survival with only 76 % of the patients surviving at 2 years,
our two more recent cohorts from the 1980s to the twenty-first
century did present with a higher survival rate of 91 and 92%,
respectively.
The shunt-relatedmortality rate of 3% at 2 years in patients
treated with VAS in 1967–1970, combined with the fact that
there were a high proportion of children dying of unknown
cause, made us to propose that treatment with shunt in the
1960s was associated with a higher risk of mortality due to
treatment compared with more recent years. No early shunt-
related mortality was registered in the most recent cohort.
Follow-up
CSF diversion for hydrocephalus matured in the late 1950s
and became established during the 1960s. Although shunt
failure was a recognized problem even in the early phase,
the most common practice was to wait until blockade of the
shunt forced intervention [25]. The awareness upon preven-
tive strategies to avoid complications to shunt treatment and
improve outcome in shunted individuals became clearer with
time. Becker et al. introduced a program for elective revisions
to maintain shunt function in 1960, i.e., elongation of the atrial
catheter in growth periods of the child [25]. Besides, Foltz
emphasized the importance by periodic and thorough evalua-
tion of the functioning status of the shunt (irrespective of
symptomatology) by measurement of ventricular pressure,
comparison of ventricular size, psychometric tests, and phys-
ical status of the flushing device [26].
Although the majority of the patients in the cohort from the
1960s were routinely followed, there were some exceptions.
The higher early mortality rate in the 1967–1970 cohort could
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reflect that at the time, management and follow-up had yet to
reach maturity.
Still, even today, more than 50 years later, there is no con-
sensus regarding the optimal mode of controlling these pa-
tients in regard to frequencies of visits and imaging.
The complexity and rarity of the condition make the
follow-up a specialist’s role. The role of brain imaging is much
debated. It is important to obtain a baseline cerebral imaging
to provide adequate comparison when suspicion of shunt mal-
function arises. Some authors advise a clinical visit in older
children being asymptomatic of shunt failure every second
year [27]. In our institution, newly shunted infants have sched-
uled control at 1 month, and then at 2 to 6 months. Thereafter,
in the absence of symptoms of possible shunt malfunction, we
currently perform controls at 1 to 2 years, with the frequency
decreasing as the child grows.
Limitations of the study
The retrospective nature of this study poses several methodo-
logical limitations. First, patient selection was determined by
the treating surgeon. Varying individual thresholds for deter-
mining both the need for operative intervention for hydro-
cephalus, decision upon prosthetic shunt or ETV, and the need
for repeat intervention could have an impact on patient selec-
tion, choice of treatment, and the observed failure rates.
Second, comparing results of CSF diversion in pediatric pa-
tients in three different time epochs will inevitably also reflect
the inherent differences in practice patterns and thereby influ-
ence the results. Due to the complexity of confounding fac-
tors, we have refrained from using multivariable statistical
analyses in this series. Third, because the most recent series
were performed relatively recently, the length of follow-up is
rather short, thereby limiting our ability to make comparisons
extending 2 years of duration. Taken together, these limita-
tions force us to be cautious in the interpretation of our results
and emphasize the empirical nature of our study.
Evolvement is continuous, and understanding current prac-
tices in order, hopefully, to foster future improvement calls for
knowing the long lines leading from the practice of the past to
that of the present.
Conclusions
The case-mix in pediatric patients in need for permanent CSF
diversion has evolved during half a century. There has been a
marked decline in the proportion of infants with neural tube
defects and IVH in need for treatment due to intracranial hy-
pertension. Almost one third of the children in need for CSF
diversion in 2009–2013 were diagnosed with CNS tumor.
Patients tend to be older at initial treatment in the twenty-
first century compared to 50 years ago. Although the need
for re-do surgery does not differ notably in the three time
epochs, early-mortality (at 1 and 2 years) seems to have been
lowered. Severe shunt failure may take place at any time, even
after prolonged periods of stable shunt functioning, indicating
the need of life-long follow-up.
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